Man Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200,000	Closed	-$4.61M	–	2086
2020 Q4	$4.61M	Buy	+200,000	New	+$4.61M	0.02%	851